Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor (Q69822568)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3849980%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3849980%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

author name string

D S Hoon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3849980%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

I A Ramshaw

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3849980%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3849980%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

5 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3849980%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3849980%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3849980%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

175-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3849980%20AND%20SRC:MED&resulttype=core&format=json

Effect of Cyclophosphamide on Immunological Control Mechanisms

5 October 2019

cites work

1 reference

12 December 2020

Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour

1 reference

12 December 2020

Suppressor Cells: Permitters and Promoters of Malignancy?

1 reference

12 December 2020

Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action

1 reference

12 December 2020

Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency

1 reference

12 December 2020

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

12 December 2020

Cyclophosphamide and urinary bladder toxicity

1 reference

12 December 2020

Regulation of the immune response II. Repressor T cells in cyclophosphamide-induced tolerant mice

1 reference

12 December 2020

Restoration of cyclophosphamide-induced suppression of thymus-derived cytotoxic cell generation by normal thymocytes

1 reference

12 December 2020

A 6-thioguanine-resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic.

1 reference

12 December 2020

Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide

1 reference

12 December 2020

Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide

1 reference

12 December 2020

Interference of anti-tumor and immunosuppressive effects of cyclophosphamide in tumor-bearing rats. Analysis of factors determining resistance or susceptibility to a subsequent tumor challenge

1 reference

12 December 2020

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

1 reference

12 December 2020

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

1 reference

12 December 2020

Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors

1 reference

12 December 2020

The relationship between tumor antigens and alloantigens: cross-reactivity due to differential context of T cell antigen recognition

1 reference

12 December 2020

Circulating immune complexes and immunoglobulin M-class rheumatoid factor in rats bearing mammary adenocarcinomas which vary in ability to metastasize

1 reference

12 December 2020